A subtype of cancer‐associated fibroblast expressing syndecan‐2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer.
Saved in:
| Title: | A subtype of cancer‐associated fibroblast expressing syndecan‐2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer. |
|---|---|
| Authors: | Sung, Ji‐Yong1 (AUTHOR) 5rangepineapple@gmail.com, Cheong, Jae‐Ho2 (AUTHOR) jhcheong@yuhs.ac, Shin, Kihye3,4 (AUTHOR), Kim, Eui Tae3,4 (AUTHOR) tae@jejunu.ac.kr |
| Source: | Clinical & Translational Medicine. Dec2024, Vol. 14 Issue 12, p1-7. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20011326 |
|---|---|
| DOI: | 10.1002/ctm2.70079 |
